Latest report
Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics
Steve Poile : May 2, 2012 10:25 AM : Deal type reports, Featured, ReportsThis report provides details of the latest co-promotion and co-marketing agreements announced in the pharmaceutical, biotechnology and diagnostic sectors. Fully revised and updated, the report provides details of co-promotion and co-marketing agreements from 2007 to early 2012. more »
Latest partnering news
BMS and Tsinghua University in structural biology research pact
May 15, 2012 : Big Pharma, Bristol-Myers Squibb, partnering
Bristol-Myers Squibb Company and Tsinghua University of Beijing, announced the formation of a multi-year strategic partnership more »
Menarini licenses rights to Priligy
May 15, 2012 : Big Pharma, licensing, Menarini, partnering
Furiex Pharmaceuticals and Menarini Group announced that they have entered into a license agreement by which Furiex will license to Menarini rights to commercialize Priligy in Europe, most of Asia, Africa, Latin America and the Middle East more »
Latest M&A news
Kensey Nash Sued by Investor Over $360 Million DSM Bid
May 14, 2012 : dealtalk, M&A
Kensey Nash, a maker of absorbable cardiac medical devices, was sued by a stockholder contending investors will be shortchanged in a planned $360 million bid from Royal DSM more »
Novartis acquires specialty dermatology company Fougera
May 4, 2012 : Big Pharma, M&A, Novartis
Novartis is buying specialty dermatology generics firm Fougera Pharmaceuticals for $1.525 billion in cash more »
Latest financing news
OncoMed seeks $115 million IPO
May 15, 2012 : financings
OncoMed offers $115M IPO bet on cancer stem cell work more »
Fresenius in public offering for $1.31 billion
May 14, 2012 : financings
Fresenius successfully completes capital increase more »
Latest Dealtalk
Amag Pharma falls after ending sale talks
May 15, 2012 : dealtalk, M&A
Shares of Amag Pharmaceuticals Inc. sank Thursday, a day after the anemia drug maker said it is no longer considering selling itself more »
Kensey Nash Sued by Investor Over $360 Million DSM Bid
May 14, 2012 : dealtalk, M&A
Kensey Nash, a maker of absorbable cardiac medical devices, was sued by a stockholder contending investors will be shortchanged in a planned $360 million bid from Royal DSM more »
Featured reports
Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics
Publication date: May 2012
Royalty Financing Terms and Agreements
Publication date: May 2012
Cancer Monoclonal Antibody Partnering Terms and Agreements
Publication date: April 2012
Recent insights
The trouble with tech M&A
May 15, 2012
Can Pharma Turn the Oceanliner Around?
May 14, 2012
Points of view
Hologic buys Gen-Probe for $3.7 billion
May 1, 2012
Jazz makes another acquisition, this time Eusa
April 30, 2012
Scorecard
Current Partnering provides access to key deal metrics for all leading partnering, M&A and financings - plus big pharma partnering activity and R&D spend metrics.
Available scorecards:
